7 Results for "

Resiquimod

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "Resiquimod" in MCE Product Catalog:

116
116 Cited Publications
Cat. No.: HY-13740
CAS No.: 144875-48-9
Purity:  99.87%
Synonyms: R848; S28463
Resiquimod is a Toll-like receptor 7 and 8 (TLR7/TLR8) agonist that induces the upregulation of cytokines such as TNF-α, IL-6 and IFN-α.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13740S
CAS No.: 2252319-44-9
Purity:  99.84%
Synonyms: R848-d5; S28463-d5
Resiquimod-d5 is deuterium labeled Resiquimod. Resiquimod is a Toll-like receptor 7 and 8 (TLR7/TLR8) agonist that induces the upregulation of cytokines such as TNF-α, IL-6 and IFN-α .
loading...
    loading...
Cat. No.: HY-13740G
CAS No.: 144875-48-9
Synonyms: R848 (GMP); S28463 (GMP)
Resiquimod (R848) (GMP) is Resiquimod (HY-13740) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. Resiquimod is a Toll-like receptor 7 and 8 (TLR7/TLR8) agonist. Resiquimod (GMP) can induce human mMDSC to mature into inflammatory macrophages .
loading...
    loading...
Cat. No.: HY-13740R
CAS No.: 144875-48-9
Synonyms: R848 (Standard); S28463 (Standard)
Resiquimod (Standard) is the analytical standard of Resiquimod. This product is intended for research and analytical applications. Resiquimod is a Toll-like receptor 7 and 8 (TLR7/TLR8) agonist that induces the upregulation of cytokines such as TNF-α, IL-6 and IFN-α.
loading...
    loading...
Cat. No.: HY-W757258
CAS No.: 2469756-03-2
O-Desethyl resiquimod-d6 is the deuterium labeled O-Desethyl Resiquimod (HY-W749241).
loading...
    loading...
Cat. No.: HY-W757658
O-Desethyl resiquimod-O-acetate-d6 is the deuterium labeled O-Desethyl resiquimod-O-acetate.
loading...
    loading...
Cat. No.: HY-169478
CAS No.: 2924606-55-1
Target:  

Liposome

Research Areas:  

Cancer

Lipid N2-3L is an ionizable cationic lipid (pKa = 8.99) that can be used to generate supramolecular lipid nanoparticles (SMLNPs) for mRNA delivery. Lipid nanoparticles formed by encapsulating a luciferase reporter gene with Lipid N2-3L were detected to accumulate in the lymph nodes of mice, indicating that they can effectively enter the mouse immune system. Lipid nanoparticles formed by encapsulating ovalbumin mRNA and the TLR7/8 agonist Resiquimod (HY-13740) with Lipid N2-3L were able to reduce tumor volume and increase survival in the MC-38-OVA mouse colon cancer model. Lipid N2-3L can be used in the research of drug delivery for cancer-related therapies .
loading...
    loading...